Physician profile

Jay Goldberg

Beverly Hills, CA

NPI 1467492082

$3,101.17

in general payments reported to CMS, 2019-2025

22 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $1,399.87 2019-2022
Allergan, INC. $234.78 2019-2020
Therapeuticsmd, INC. $166.12 2019-2021
Evofem Biosciences, INC. $157.21 2021
Bayer Healthcare Pharmaceuticals INC. $156.79 2019-2022
Pfizer INC. $131.12 2019-2022
Myovant Sciences INC. $118.62 2021-2022
Daiichi Sankyo INC. $117.93 2019-2022
Hologic Sales and Service, LLC $112.72 2019-2020
Coopersurgical, INC. $106.70 2020-2021
Amag Pharmaceuticals, INC. $104.48 2019-2020
Vertical Pharmaceuticals, LLC $64.41 2019
Baxter Healthcare $48.96 2021
Duchesnay USA Incorporated $36.83 2019
Mayne Pharma Commercial LLC $34.51 2021
Show all 22 companies
CompanyGeneral paymentsYearsTop products
Agile Therapeutics, INC. $23.53 2022
Ferring Pharmaceuticals INC. $20.24 2019
Roche Diagnostics Corporation $18.13 2019
Mission Pharmacal Company $14.84 2019
Lupin INC. $13.50 2019
Covidien Lp $10.92 2019
Channel Medsystems, INC. $8.96 2022

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Jay Goldberg

$3,101.17

in general payments reported 2019-2025

Years
2019-2022
Top company
Abbvie INC.

https://glasscript.com/doctor/20564/jay-goldberg

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.